Home » Topics » Conferences

Conferences
RSS

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

CRISP/Cas9 modulation of utrophin as a strategy to treat DMD

Oct. 27, 2021

188Re-Rituximab shows promise for treating CD20-overexpressing cancers

Oct. 27, 2021

Ec1-LoPE DARPin-toxin fusion protein evaluated with trastuzumab for ovarian cancer

Oct. 27, 2021

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Oct. 27, 2021

Oxytocin receptor hypermethylation tied to obsessive-compulsive disorder

Oct. 26, 2021

Gluk2-targeted siRNA-based gene therapy for drug-resistant temporal lobe epilepsy

Oct. 26, 2021

AKAP11 identified as shared risk gene in bipolar disorder and schizophrenia

Oct. 26, 2021

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...